Literature DB >> 14660563

Nek9, a novel FACT-associated protein, modulates interphase progression.

Bertrand Chin-Ming Tan1, Sheng-Chung Lee.   

Abstract

The heterodimeric Spt16-Pob3/DUF/FACT complex is a class of chromatin structure modulators with important roles in replication and transcription. Although regarded as a transcription elongator for chromatin template, little is known about the mode of action and involvement in other molecular processes of the mammalian FACT. Here we report the identification of a novel interacting and functional partner of FACT, Nek9. Nek9 forms a stable, approximately 600-kDa complex with FACT in the interphase nuclei. Its active form is characterized by phosphorylation-dependent electrophoretic mobility shift and phosphorylation at a conserved residue within the activation loop (Thr(210)). When complexed with FACT, Nek9 exhibits markedly elevated phosphorylation on Thr(210). Cell cycle analysis on the Nek9(dsRNAi) cells directly implicated Nek9 in maintaining proper G(1) and S progression, a role temporally correlated to the formation of a phospho-Nek9-FACT complex. Collectively, these observations provide evidence that Nek9, potentially as an active enzymatic partner of FACT, mediates certain FACT-associated cellular processes, which are ultimately essential for interphase progression.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14660563     DOI: 10.1074/jbc.M311477200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  24 in total

1.  The Dual Nature of Nek9 in Adenovirus Replication.

Authors:  Richard Jung; Sandi Radko; Peter Pelka
Journal:  J Virol       Date:  2015-12-16       Impact factor: 5.103

2.  Functional cooperation between FACT and MCM helicase facilitates initiation of chromatin DNA replication.

Authors:  Bertrand Chin-Ming Tan; Cheng-Ting Chien; Susumu Hirose; Sheng-Chung Lee
Journal:  EMBO J       Date:  2006-08-10       Impact factor: 11.598

3.  Quantitative phosphokinome analysis of the Met pathway activated by the invasin internalin B from Listeria monocytogenes.

Authors:  Tobias Reinl; Manfred Nimtz; Claudia Hundertmark; Thorsten Johl; György Kéri; Jürgen Wehland; Henrik Daub; Lothar Jänsch
Journal:  Mol Cell Proteomics       Date:  2009-07-29       Impact factor: 5.911

Review 4.  In depth analysis of kinase cross screening data to identify chemical starting points for inhibition of the Nek family of kinases.

Authors:  C I Wells; N R Kapadia; R M Couñago; D H Drewry
Journal:  Medchemcomm       Date:  2017-12-08       Impact factor: 3.597

5.  Identification of herpesvirus proteins that contribute to G1/S arrest.

Authors:  Patrick Paladino; Edyta Marcon; Jack Greenblatt; Lori Frappier
Journal:  J Virol       Date:  2014-02-05       Impact factor: 5.103

6.  FACT Proteins, SUPT16H and SSRP1, Are Transcriptional Suppressors of HIV-1 and HTLV-1 That Facilitate Viral Latency.

Authors:  Huachao Huang; Netty Santoso; Derek Power; Sydney Simpson; Michael Dieringer; Hongyu Miao; Katerina Gurova; Chou-Zen Giam; Stephen J Elledge; Jian Zhu
Journal:  J Biol Chem       Date:  2015-09-16       Impact factor: 5.157

7.  Functional cooperation between FACT and MCM is coordinated with cell cycle and differential complex formation.

Authors:  Bertrand Chin-Ming Tan; Hsuan Liu; Chih-Li Lin; Sheng-Chung Lee
Journal:  J Biomed Sci       Date:  2010-02-16       Impact factor: 8.410

Review 8.  Building it up and taking it down: the regulation of vertebrate ciliogenesis.

Authors:  Nicole Santos; Jeremy F Reiter
Journal:  Dev Dyn       Date:  2008-08       Impact factor: 3.780

9.  New mutant versions of yeast FACT subunit Spt16 affect cell integrity.

Authors:  Allyson F O'Donnell; Jennifer R Stevens; Rosemarie Kepkay; Christine A Barnes; Gerald C Johnston; Richard A Singer
Journal:  Mol Genet Genomics       Date:  2009-09-01       Impact factor: 3.291

10.  FACT facilitates chromatin transcription by RNA polymerases I and III.

Authors:  Joanna L Birch; Bertrand C-M Tan; Kostya I Panov; Tatiana B Panova; Jens S Andersen; Tom A Owen-Hughes; Jackie Russell; Sheng-Chung Lee; Joost C B M Zomerdijk
Journal:  EMBO J       Date:  2009-02-12       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.